|
|
|
|
|
by jwstanly
843 days ago
|
|
The skepticism is understandable at least academically. From my understanding FAI isn't prioritizing clinical trials because 1) their individualized process with AI/ML work isn't aligned with classical physician/allergist work and 2) that same time could be spent to grow the program's operation and get more patients off the waitlist. The individualized work is also why TIP doesn't scale-- even FAI itself hasn't opened offices outside of SoCal yet (east coast patients like myself have been begging internally for years for them to open locations nationwide). Everyone would love to see FAI be more transparent, but just because they aren't doesn't mean the program doesn't work. Arguing "its not clinically proven, therefore it's not legitimate" feels pedantic when there's thousands of us in remission. |
|